It’s a step forward for the Food and Drug Administration’s approach to cannabis-derived medications. This week it approved a new drug, Epidiolex, that is a formulation of cannabidiol - CBD for short - to treat rare and severe forms of epilepsy. Wendy Gibson is a Field Organizer for The Drug Policy Forum, and The Medical Cannabis Coalition of Hawaii who has spent years advocating for the use of cannabis-derived medications - and although she has reservations about this one, she welcomes the FDA’s changing attitude.
